Abstract:Background: The role of purinergic P2X7 receptor (P2X7R) is of interest due to its involvement in inflammation and mediating immune cell responses. P2X7R is particularly implicated in the development of inflammatory bowel disease (IBD). However, the extent of the actions of P2X7R in the gastrointestinal (GI) system under physiological and pathophysiological conditions remains to be elucidated. This systematic review aimed to identify, summarize and evaluate the evidence for a critical role of P2X7R in the GI system. Methods: We searched PubMed, Embase and Scopus with search terms pertained to P2X7R in the GI system in disease or physiological state, including “P2X7 or P2X7 receptor or purinergic signaling” in combination with any of the terms “intestine or colon or gut or gastrointestinal,” “pathology or inflammation or disease or disorder,” and “physiology or expression.” Titles and abstracts were screened for potentially eligible full texts, and animal and human studies published in English were included in this study. Data were extracted from papers meeting inclusion criteria. Meta-analysis was not feasible given the study diversity. Results: There were 48 papers included in this review. We identified 14 experimental colitis models, three sepsis models and one ischemia-reperfusion injury model. Among them, 11 studies examined P2X7R in GI infections, six studies on immune cell regulation, four studies on GI inflammation, two studies on GI malignancies, three studies involving intestinal injury due to various causes, two studies on ATP-activated P2X7R in the GI system and two studies on metabolic regulation. Conclusion: Evidence supports P2X7R mediating inflammation and immune cell responses in GI inflammation, infections and injury due to IBD and other challenges to the intestinal wall. P2X7R inhibition by gene knockout or by application of P2X7R antagonists can reduce tissue damage by suppressing inflammation. P2X7R is also implicated in GI malignancies and glucose and lipid homeostasis. P2X7R blockade, however, did not always lead to beneficial outcomes in the various pathological models of study.

Special Issue of International Journal of Molecular Sciences (IJMS) “Purinergic P2 Receptors: Structure and Function”

Editorial - Purinergic signalling: 50 years

Special Issue of International Journal of Molecular Sciences “Opioid Receptors and Endorphinergic Systems 2.0”

Purinergic P2 Receptors: Novel Mediators of Mechanotransduction

Recent progress in the structural biology of P2X receptors

Unraveling the Complexities of Mast Cells in Health and Disease

Molecular Pharmacology and Physiology of Insect Biogenic Amine Receptors

Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists

"Recent Advances in Ion Channels and Ion Channelopathies"

From purines to purinergic signalling: molecular functions and human diseases

Understanding the Role of Purinergic P2X7 Receptors in the Gastrointestinal System: A Systematic Review

P2X7 receptors: a bibliometric review from 2002 to 2023

Special Issue "Genetic, Functional and Therapeutic Aspects of Procoagulant and Anticoagulant Factors"

Purinergic signaling and the functioning of the nervous system cells

The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications

Special Issue—"Natural Products That Might Change Society"

Purine and purinergic receptors in health and disease

Molecular Study of Sudden Cardiac Death

A patent review of P2X7 receptor antagonists to treat inflammatory diseases (2018–present)

Pathophysiological Role of Purinergic P2X Receptors in Digestive System Diseases

Structural insights into the human P2X1 receptor and ligand interactions